Cost effectiveness of ibandronate for the prevention of fractures in inflammatory bowel disease-related osteoporosis - Cost-utility analysis using a Markov model

Erstveröffentlichung

2008

Authors

Kreck, Simon

Klaus, Jochen

Leidl, Reiner

von Tirpitz, Christian

Konnopka, Alexander

et al.

Wissenschaftlicher Artikel

Published in

PharmacoEconomics ; 26 (2008), 4. - S. 311-328. - ISSN 1170-7690. - eISSN 1179-2027

Link to publication

https://dx.doi.org/10.2165/00019053-200826040-00004

Institutions

UKU. Klinik für Innere Medizin I

Subject headings

[Free subject headings]: BONE-MINERAL DENSITY | INCIDENT VERTEBRAL FRACTURE | HIP FRACTURE | POSTMENOPAUSAL WOMEN | CROHNS-DISEASE | EXCESS MORTALITY | ANTIRESORPTIVE AGENTS | ECONOMIC EVALUATIONS | RISK REDUCTION | ALENDRONATE
[DDC subject group]: DDC 330 / Economics | DDC 610 / Medicine & health

Metadata

Show full item record